All In Biotech

Drug Trial Radar · NCT07378644

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

A Phase 2/3 Randomized, Double Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Jan 6, 2026

Primary completion

Dec 2028

Study completion Aug 2029

Sponsor

Lead sponsor
Skyhawk Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jan 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of participants with HD. This study includes men and women aged 25 and older who have HD confirmed by genetic testing and meet certain requirements for physical ability and independence.

Conditions

  • Huntington Disease

Interventions

  • SKY-0515Drug

    Type: Small molecule Dosage Level(s): Low, mid, high Route of Administration: Oral Dosage Frequency: Once daily Blinded Treatment Duration: 18 months Use: Experimental

  • SKY-0515 PlaceboDrug

    Route of Administration: Oral Dosage Frequency: Once daily Blinded Treatment Duration: 18 months Use: Experimental

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Z-score from the Composite Unified Huntington's Disease Rating Scale (cUHDRS)Time frame: 72 weeks

Locations

31 sites in 10 countries. Site status is shown where the registry gives one.

  • CenExel Denver CO

    Englewood, Colorado · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Not yet recruiting

  • Massachusetts General Hospital

    Charlestown, Massachusetts · Not yet recruiting

  • The Ohio State University

    Columbus, Ohio · Not yet recruiting

  • Hospital El Cruce

    Buenos Aires, Buenos Aires, Argentina · Recruiting

  • Buenos Aires British Hospital

    CABA, Buenos Aires, Argentina · Recruiting

  • IADIN (Instituto Argentino de Investigación Neurológica)

    CABA, Buenos Aires, Argentina · Recruiting

  • CINME Centro de Investigaciones Metabólicas

    CABA, Buenos Aires, Argentina · Recruiting

  • Sanatorio Mater Dei

    CABA, Buenos Aires, Argentina · Recruiting

  • Fundación Scherbovsky

    Mendoza, Mendoza Province, Argentina · Recruiting

  • Centro de Pesquisas Clínicas do Hospital das Clínicas da Universidade Federal de Minas Gerais - Filial EBSERH

    Belo Horizonte, Minas Gerais, Brazil · Enrolling by invitation

  • Hospital Angelina Caron

    Campina Grande do Sul, Paraná, Brazil · Recruiting

  • PUCPR - Centro de Pesquisa da Pontifícia Universidade Católica do Paraná

    Curitiba, Paraná, Brazil · Recruiting

  • Instituto de Neurologia de Curitiba

    Curitiba, Paraná, Brazil · Recruiting

  • Hospital Universitario Pedro Ernesto (HUPE)

    Rio de Janeiro, Rio de Janiero, Brazil · Recruiting

  • Hospital Universitário Onofre Lopes (HUOL)

    Natal, Rio Grande do Norte, Brazil · Not yet recruiting

  • Faculdade de Medicina de Ribeirão Preto - FMRP

    Ribeirão Preto, São Paulo, Brazil · Not yet recruiting

  • Hospital da Universidade Federal de São Paulo - UNIFESP

    São Paulo, São Paulo, Brazil · Not yet recruiting

  • PSEG Centro de Pesquisa Clinica

    São Paulo, São Paulo, Brazil · Active not recruiting

  • North York General Hospital

    Toronto, Ontario, Canada · Recruiting

  • Pontificia Universidad Católica de Chile

    Santiago, Santiago Metropolitan, Chile · Recruiting

  • CETRAM (Centro de Trastornos del Movimiento)

    Santiago, Santiago Metropolitan, Chile · Recruiting

  • Clínica de la Costa S.A.S

    Barranquilla, Atlántico, Colombia · Recruiting

  • Pineo Medical Ecosystem

    Tbilisi, Georgia · Recruiting

  • Simon Khechinashvili University Hospital

    Tbilisi, Georgia · Recruiting

  • Isar-Amper-Klinikum, Zentrum für Neuro- und Gerontopsychiatrie (ZNGP)

    Taufkirchen, Germany · Not yet recruiting

  • Hospital Clinic de Barcelona

    Barcelona, Spain · Not yet recruiting

  • Sant Pau Hospital

    Barcelona, Spain · Not yet recruiting

  • Hospital Universitario Ramon y Cajal

    Madrid, Madrid, Spain · Not yet recruiting

  • University College of London

    London, United Kingdom · Recruiting

  • NeuroClnx

    Motherwell, Lanarkshire, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.